Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit

被引:38
作者
Luis Lopez-Campos, Jose [1 ,2 ]
Hartl, Sylvia [3 ]
Pozo-Rodriguez, Francisco [2 ,4 ]
Roberts, Michael [5 ]
机构
[1] Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Seville, Spain
[2] Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain
[3] Ludwig Boltzmann Inst COPD & Resp Epidemiol, Vienna, Austria
[4] Hosp 12 Octubre, Inst Invest I 12, E-28041 Madrid, Spain
[5] Univ London, Barts & London Sch Med & Dent, London WC1E 7HU, England
来源
PLOS ONE | 2015年 / 10卷 / 04期
关键词
OBSTRUCTIVE PULMONARY-DISEASE; C-REACTIVE PROTEIN; PROCALCITONIN; MOXIFLOXACIN; MANAGEMENT; OUTCOMES; SPUTUM; SEX;
D O I
10.1371/journal.pone.0124374
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective Appropriate use of antibiotics in the management of hospitalised patients with COPD exacerbations is defined within the GOLD strategy. This paper analyses the factors associated with antibiotic prescribing in patients to better understand how prescribing may be improved. Methods The European COPD audit was a study of clinical care in 384 hospitals from 13 European countries between 2010 and 2011 enrolling 16018 patients. Those admitted to hospital due to a clinician-made diagnosis of exacerbation of COPD at the time of discharge were audited. We defined antibiotic prescribing compliance as consistent with the GOLD 2010 recommendations. Two different multivariate models were used to evaluate factors associated with the prescription of antibiotics and the guideline-compliant prescriptions. Results Overall 86% of admissions were given antibiotics but only 61.4% cases met the GOLD recommendations. Antibiotics were more likely to be given in hospital and at discharge if received prior to admission. Antibiotic prescription was more likely in patients who met the GOLD recommendations and in those with radiological consolidation but there was also a significant use of antibiotics in patients who did not meet either criterion. Patients cared for on a Respiratory Ward were more likely to receive GOLD compliant antibiotic management. Conclusions The present study describes the audited in-hospital antibiotic prescription for COPD exacerbation across different European countries. In general, there is an apparent overuse of antibiotics likely to be associated with both patient and practice-related variables.
引用
收藏
页数:12
相关论文
共 24 条
[1]   Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes [J].
Aryal, Shambhu ;
Diaz-Guzman, Enrique ;
Mannino, David M. .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 :1145-1154
[2]   Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations [J].
Brusse-Keizer, Marjolein ;
VanderValk, Paul ;
Hendrix, Ron ;
Kerstjens, Huib ;
van der Palen, Job .
BMJ OPEN RESPIRATORY RESEARCH, 2013, 1 (01)
[3]   Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections:: cluster-randomised, single-blinded intervention trial [J].
Christ-Crain, M ;
Jaccard-Stolz, D ;
Bingisser, R ;
Gencay, MM ;
Huber, PR ;
Tamm, M ;
Müller, B .
LANCET, 2004, 363 (9409) :600-607
[4]   Procalcitonin vs C-Reactive Protein as Predictive Markers of Response to Antibiotic Therapy in Acute Exacerbations of COPD [J].
Daniels, Johannes M. A. ;
Schoorl, Marianne ;
Snijders, Dominic ;
Knol, Dirk L. ;
Lutter, Rene ;
Jansen, Henk M. ;
Boersma, Wim G. .
CHEST, 2010, 138 (05) :1108-1115
[5]   Risk of Pneumonia with Inhaled Corticosteroid versus Long-Acting Bronchodilator Regimens in Chronic Obstructive Pulmonary Disease: A New-User Cohort Study [J].
DiSantostefano, Rachael L. ;
Sampson, Tim ;
Hoa Van Le ;
Hinds, David ;
Davis, Kourtney J. ;
Bakerly, Nawar Diar .
PLOS ONE, 2014, 9 (05)
[6]   Pneumonic and Nonpneumonic Exacerbations of COPD Inflammatory Response and Clinical Characteristics [J].
Huerta, Arturo ;
Crisafulli, Ernesto ;
Menendez, Rosario ;
Martinez, Raquel ;
Soler, Nestor ;
Guerrero, Monica ;
Montull, Beatriz ;
Torres, Antoni .
CHEST, 2013, 144 (04) :1134-1142
[7]   Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis and COPD: a systematic review and meta-analysis [J].
Liu, Kai-Xiong ;
Xu, Bing ;
Wang, Jie ;
Zhang, Jing ;
Ding, Hai-Bo ;
Ariani, Felinda ;
Qu, Jie-Ming ;
Lin, Qi-Chang .
JOURNAL OF THORACIC DISEASE, 2014, 6 (03) :221-229
[8]   Predictors for antibiotic prescribing in patients with exacerbations of COPD in general practice [J].
Llor, Carl ;
Bjerrum, Lars ;
Munck, Anders ;
Hansen, Malene P. ;
Cordoba, Gloria Cristina ;
Strandberg, Eva Lena ;
Ovhed, Ingvar ;
Radzeviciene, Ruta ;
Cots, Josep M. ;
Reutskiy, Anatoliy ;
Caballero, Lidia .
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2013, 7 (03) :131-137
[9]   European COPD Audit: design, organisation of work and methodology [J].
Luis Lopez-Campos, Jose ;
Hartl, Sylvia ;
Pozo-Rodriguez, Francisco ;
Roberts, C. Michael .
EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (02) :270-276
[10]   UK National COPD Resources and Outcomes Project 2008: Patients with Chronic Obstructive Pulmonary Disease Exacerbations Who Present with Radiological Pneumonia Have Worse Outcome Compared to Those with Non-Pneumonic Chronic Obstructive Pulmonary Disease Exacerbations [J].
Myint, Phyo Kyaw ;
Lowe, Derek ;
Stone, Robert A. ;
Buckingham, Rhona J. ;
Roberts, C. Michael .
RESPIRATION, 2011, 82 (04) :320-327